Dallas Meeting Comments

Quote






























anonymous said:
I left my previous employer for this?! I'm going to lose it. See you all at the bar in a few.
Click to expand...

You'll be fine and will make much better bonus with Austedo and much more enjoyable product to sell where you don't have to worry about an over crowed LAI market. You'll get your Uzedy back in 6 months or so.
 






anonymous said:
You'll be fine and will make much better bonus with Austedo and much more enjoyable product to sell where you don't have to worry about an over crowed LAI market. You'll get your Uzedy back in 6 months or so.
Click to expand...

I would rather sell Austedo than Uzedy anyway. It’s just another LAI with no difference in efficacy than the rest out there.
 






Austedo reps are gonna be furious about this move. Especially if this LAI does not get approved. You are talking layoffs again. Tevas current Austedo reps will start looking for new jobs. They will not wait around to find out some of these new reps will be replacing them. Teva will probably ask the Austedo reps to help get them in offices. What a mess. Teva just does not want to keep an Austedo sales force. Many are probably wishing they jumped ship to Neurocrine a few months ago now because this is a really stupid move by Teva.
 
























Uzedy rep,here. I know Austedo had a layoff of the sales force last year. Now, the Austedo sales force is huge with the so-called Uzedy reps coming on board. Does it make sense to hire all the Uzedy reps before approval, add them to an already recently downsized Austedo team, and keep them on the payroll for possibly longer than a year waiting on a backlogged FDA to review it…again?

i plan on pushing out my Austedo rep, because I know damn well they make more than I do, so when the reorg comes around again they are more likely to keep me. Funny isn’t it. The Austedo reps will be helping us with Austedo, while we scheme to replace them! May the best man/woman win! ALL KNIVES OUT!
 






anonymous said:
Uzedy rep,here. I know Austedo had a layoff of the sales force last year. Now, the Austedo sales force is huge with the so-called Uzedy reps coming on board. Does it make sense to hire all the Uzedy reps before approval, add them to an already recently downsized Austedo team, and keep them on the payroll for possibly longer than a year waiting on a backlogged FDA to review it…again?

i plan on pushing out my Austedo rep, because I know damn well they make more than I do, so when the reorg comes around again they are more likely to keep me. Funny isn’t it. The Austedo reps will be helping us with Austedo, while we scheme to replace them! May the best man/woman win! ALL KNIVES OUT!
Click to expand...

So, you are bragging about being under paid? And you think that makes you a good rep? Lol!
 






anonymous said:
So, you are bragging about being under paid? And you think that makes you a good rep? Lol!
Click to expand...

Who said being underpaid made someone a good rep? I believe they meant that it might make them a little more desirable if a reorg comes becomes they make less than you. When 2 people are calling on the same docs, it can be tough to ascertain who is making the most impact.
 






anonymous said:
Who said being underpaid made someone a good rep? I believe they meant that it might make them a little more desirable if a reorg comes becomes they make less than you. When 2 people are calling on the same docs, it can be tough to ascertain who is making the most impact.
Click to expand...

LOL! Ok, I said cheap, you say less expensive. Fact is he/she does not understand what he is talking about. Austedo Reps had a "Purge" by Neurocrine back in January because they were paid so little. The LAI reps were actually paid more coming in as reps then Austedo Reps when hired. Now it is possible that the reps that have been with teva for 5,10,20 years are paid more because of annual increases....but if you look at Glassdoor and job postings on Linked-In, the LAI reps were paid around $9k-15k more on salary. Granted the bonuses could be different, but salaries are higher for Uzedy reps then Austedo Reps when it comes to pay at day of hire.

This is why I laughed at the guy telling me he is less expensive. Because that means he either stinks at selling himself and was paid less, or does not know that most reps selling Uzedy are making well over $100K. Most reps that came in for Austedo were making around $93-$100k when brought on board.
 






anonymous said:
Uzedy rep,here. I know Austedo had a layoff of the sales force last year. Now, the Austedo sales force is huge with the so-called Uzedy reps coming on board. Does it make sense to hire all the Uzedy reps before approval, add them to an already recently downsized Austedo team, and keep them on the payroll for possibly longer than a year waiting on a backlogged FDA to review it…again?

i plan on pushing out my Austedo rep, because I know damn well they make more than I do, so when the reorg comes around again they are more likely to keep me. Funny isn’t it. The Austedo reps will be helping us with Austedo, while we scheme to replace them! May the best man/woman win! ALL KNIVES OUT!
Click to expand...

If uzedy is approved, those reps will move back. If it is rejected by the fda again...that's gonna be the interesting part. Will they let go of only the Uzedy reps like a contract sales force or will teva do a massive reorg of all sales divisions? Only a few people know that answer. The uzedy reps territories are so big and some are hospital reps which means they do not fit austedo geographies. So the likelihood of them being kept If uzedy is rejected is unlikely. I would bet they would use some uzedy reps for backfill and let the rest go. Teva will avoid another reorganization. Look at all the sales divisions they dropped in the last 2yrs and 2 reorganizations on top of it. Teva is trying to create stability. Especially for their austedo sales force. I see only one option if uzedy does not get approved and only one option if it does.
 






Good points. But can teva keep uzedy reps for a whole year? The company is in debt with little cash flow. I would think teva is rethinking uzedy and will decide in a month or two if they will keep them or lay them off. Letting them know they will be brought back once uzedy is approved. I am betting they will lay them off and bring them back. Teva just has too much debt to carry an ancillary sales division cutting into very little profits.
 






I could be wrong but Teva is not going to walk away from this after investing $$$. It all depends on how quickly the resubmit goes. 1-3 months = no problems. 6 months rep salary is a drop in the bucket compared to investment and profit potential. 6-9 months will be a problem. Launch will happen, question when and who.
Realignment will happen in 1.5 to 2 years when they start to combine responsibility for both.
 






anonymous said:
I could be wrong but Teva is not going to walk away from this after investing $$$. It all depends on how quickly the resubmit goes. 1-3 months = no problems. 6 months rep salary is a drop in the bucket compared to investment and profit potential. 6-9 months will be a problem. Launch will happen, question when and who.
Realignment will happen in 1.5 to 2 years when they start to combine responsibility for both.
Click to expand...

The company has not invested as much as you think since the drug mainly came from MedinCell. Teva did invest money, but how much will they continue to invest? You are right, 1-3 month, not a problem. But it will not be 1-3 months. If it was that short, teva would not train the reps on Austedo. Which used to take 5-6 weeks for training. 6-9 months is the problem. Teva does not have the available cash to sustained a sales division with no product to sell. Adding them to the austedo teams only cuts into profits. It is a long sales cycle and a lot of pharmacy work for a script. This is not a antibiotic, this is a complex sales cycle. Let's not forget we do not even know how the Uzedy reps will be trained. Will they be taught HD to work with NS or TD to work with NP, or learn both and be split up into both sales divisions? I'm curious to see how teva handles this. I'm in the boat this drug will not get approved and throw in the towel on uzedy in 3 months. Eliminating the uzedy team. Especially if teva misses on earnings and revenue for Q1. Which is looking like it did because the whole TD and HD market slipped in q1. Neurocrine is also in bad shape for q1 with ingrezza. So, its not looking good
 






Top Bottom
Back
Quote